Hence, while vaccination should remain the basis for influenza prophylaxis [44], we suggest that along with inhibitors of viral replication, a concomitant treatment with modulators of TLR3 might be useful in the management of IAV infections, particularly in at-risk groups during periods when there is a mismatch between the epidemic strain and the vaccine strain. Here, TLR3 is linked to influenza.